z-logo
open-access-imgOpen Access
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis
Author(s) -
Takayuki Yoshino,
Éric Van Cutsem,
J. Li,
Lin Shen,
T.W. Kim,
Virote Sriuranpong,
L. Xuereb,
P. Aubel,
Ronan Fougeray,
Valérie Cattan,
Nadia Amellal,
Atsushi Ohtsu,
Robert J. Mayer
Publication year - 2022
Publication title -
esmo open
Language(s) - English
Resource type - Journals
ISSN - 2059-7029
DOI - 10.1016/j.esmoop.2022.100511
Subject(s) - kras , colorectal cancer , hazard ratio , medicine , oncology , placebo , confidence interval , mutation , gastroenterology , cancer , genetics , biology , gene , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here